English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Vallet-Regí, M., Schüth, F., Lozano, D., Colilla, M., & Manzano, M. (2022). Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? Chemical Society Reviews, 51(13), 5365-5451. doi:10.1039/D1CS00659B.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Vallet-Regí, María1, 2, Author
Schüth, Ferdi3, Author           
Lozano, Daniel1, 2, Author
Colilla, Montserrat1, 2, Author
Manzano, Miguel1, 2, Author
Affiliations:
1Chemistry in Pharmaceutical Sciences, School of Pharmacy, Universidad Complutense de Madrid, Research Institute Hospital 12 de Octubre (i + 12), Pz/Ramón y Cajal s/n, Madrid 28040, Spain, ou_persistent22              
2Networking Research Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid 28029, Spain , ou_persistent22              
3Research Department Schüth, Max-Planck-Institut für Kohlenforschung, Max Planck Society, ou_1445589              

Content

show
hide
Free keywords: -
 Abstract: The present review details a chronological description of the events that took place during the development of mesoporous materials, their different synthetic routes and their use as drug delivery systems. The outstanding textural properties of these materials quickly inspired their translation to the nanoscale dimension leading to mesoporous silica nanoparticles (MSNs). The different aspects of introducing pharmaceutical agents into the pores of these nanocarriers, together with their possible biodistribution and clearance routes, would be described here. The development of smart nanocarriers that are able to release a high local concentration of the therapeutic cargo on-demand after the application of certain stimuli would be reviewed here, together with their ability to deliver the therapeutic cargo to precise locations in the body. The huge progress in the design and development of MSNs for biomedical applications, including the potential treatment of different diseases, during the last 20 years will be collated here, together with the required work that still needs to be done to achieve the clinical translation of these materials. This review was conceived to stand out from past reports since it aims to tell the story of the development of mesoporous materials and their use as drug delivery systems by some of the story makers, who could be considered to be among the pioneers in this area.

Details

show
hide
Language(s): eng - English
 Dates: 2022-01-272022-06-012022-07-07
 Publication Status: Published in print
 Pages: 87
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1039/D1CS00659B
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Chemical Society Reviews
  Abbreviation : Chem. Soc. Rev.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: London : Royal Society of Chemistry, etc.
Pages: - Volume / Issue: 51 (13) Sequence Number: - Start / End Page: 5365 - 5451 Identifier: ISSN: 0306-0012
CoNE: https://pure.mpg.de/cone/journals/resource/110992357259182